Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000899243-22-035453

Chief Commercial Officer sold 3,044 shares at $60.04 ($182,762)

  • Chief Commercial Officer acquired 3,044 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-11-07 Exercise or conversion : show line 1 in the form +3,044 $2.21 $6,727 4,344 D
2022-11-07 Sale : show line 2 in the form −3,044 $60.04 $182,762 1,300 D
Open-market sales · 3,044 sh · avg $60.04 · $182,762

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-11-07 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −3,044 18,007 D
Loading xslF345X03/doc4.xml…